Papers
1
Total Citations
9
H-Index
1
About
C.R. Lockyer has made significant contributions to urological oncology, with a particular focus on the surgical and ablative management of localised renal cell carcinoma (RCC). Their work systematically examines how clinical practice evolves in response to technological innovation and evidence-based guidelines. Lockyer’s landmark study, “Trends in surgical and ablative treatment of localised renal cell carcinoma: A review of publication trends over 16 years (2000–2015),” has garnered 9 citations and provides a comprehensive bibliometric analysis of how treatment paradigms for RCC have shifted over time. By correlating publication patterns with real-world clinical adoption, Lockyer offers critical insights into the diffusion of nephron-sparing approaches and minimally invasive techniques. This research serves as a valuable resource for clinicians and researchers seeking to understand the interplay between academic output and surgical practice. Lockyer’s work underscores the importance of evidence synthesis in guiding treatment decisions and highlights the dynamic nature of urological oncology. Their contributions continue to inform discussions on optimal management strategies for localised renal tumours, making them a respected voice in the field.
Research Focus
Key Achievements
Top Papers
- 1